Application of PSMA-targeting magnetic nanoparticles into MRI of prostate cancer

Tse, Brian, Cowin, Gary, Soekmadji, Carolina, Jovanovic, Lidija, Thierry, Benjamin, & Russell, Pamela (2013) Application of PSMA-targeting magnetic nanoparticles into MRI of prostate cancer. In Prostate Cancer World Congress and 14th Australasian Prostate Cancer Conference, 6–10 August 2013, Melbourne, Australia.

View at publisher (open access)


This abstract is free to read on the publisher's website


Novel imaging techniques for prostate cancer (PCa) are required to improve staging and real-time assessment of therapeutic response. We performed preclinical evaluation of newly-developed, biocompatible magnetic nanoparticles (MNPs) conjugated with J591, an antibody specific for prostate specific membrane antigen (PSMA), to enhance magnetic resonance imaging (MRI) of PCa. PSMA is expressed on ∼90% of PCa, including those that are castrate-resistant, rendering it as a rational target for PCa imaging.


The specificity of J591 for PSMA was confirmed by flow cytometric analysis of several PCa cell lines of known PSMA status. MNPs were prepared, engineered to the appropriate size, labeled with DiR fluorophore, and their toxicity to a panel of PC cells was assessed by in vitro Alamar Blue assay. Immunohistochemistry, fluorescence microscopy and Prussian Blue staining (iron uptake) were used to evaluate PSMA specificity of J591-MNP conjugates. In vivo MRI studies (16.4T MRI system) were performed using live immunodeficient mice bearing orthotopic LNCaP xenografts and injected intravenously with J591-MNPs or MNPs alone.


MNPs were non-toxic to PCa cells. J591-MNP conjugates showed no compromise in specificity of binding to PSMA+ cells and showed enhanced iron uptake compared with MNPs alone. In vivo, tumour targeting (significant MR image contrast) was evident in mice injected with J591-MNPs, but not MNPs alone. Resected tumours from targeted mice had an accumulation of MNPs, not seen in normal control prostate.


Application of PSMA-targeting MNPs into conventional MRI has potential to enhance PCa detection and localization in real-time, improving patient management.

Impact and interest:

Search Google Scholar™

Citation counts are sourced monthly from Scopus and Web of Science® citation databases.

These databases contain citations from different subsets of available publications and different time periods and thus the citation count from each is usually different. Some works are not in either database and no count is displayed. Scopus includes citations from articles published in 1996 onwards, and Web of Science® generally from 1980 onwards.

Citations counts from the Google Scholar™ indexing service can be viewed at the linked Google Scholar™ search.

Full-text downloads:

3 since deposited on 09 Jul 2015
3 in the past twelve months

Full-text downloads displays the total number of times this work’s files (e.g., a PDF) have been downloaded from QUT ePrints as well as the number of downloads in the previous 365 days. The count includes downloads for all files if a work has more than one.

ID Code: 85247
Item Type: Conference Item (Other)
Refereed: No
Additional Information: Abstract published in BJU International Special Issue: Abstracts of the Prostate Cancer World Congress & 14th Australasian Prostate Cancer Conference, Melbourne, Australia, 6–10 August 2013, Volume 112, Issue Supplement S1, pages 34–35, August 2013
DOI: 10.1111/bju.12293
ISSN: 1464-410X
Divisions: Current > Institutes > Institute of Health and Biomedical Innovation
Copyright Owner: Copyright 2013 The Authors
Deposited On: 09 Jul 2015 22:33
Last Modified: 25 Jun 2017 02:01

Export: EndNote | Dublin Core | BibTeX

Repository Staff Only: item control page